Joint Task Force to Counter Illicit Synthetic Narcotics Act of 2025
Summary
What This Bill Does
The Joint Task Force to Counter Illicit Synthetic Narcotics Act creates a central federal entity for synthetic opioid and narcotics enforcement. The task force includes DOJ components such as DEA, FBI, assistant U.S. attorneys, and trial attorneys; Treasury components such as the Counter-Fentanyl Strike Force, IRS Criminal Investigation, FinCEN, OFAC, and intelligence offices; DHS components such as HSI, CBP's National Targeting Center, ICE, and the Coast Guard; plus State, Commerce, Defense, ODNI, and other agencies the Director chooses. A Senate-confirmed Director, paid at Executive Schedule level II, reports to the Attorney General and must report and brief Congress every 180 days on goals, agency collaboration, funding and staffing needs, budget priorities, investigations, raids, assets seized, assets forfeited, indictments, convictions, and PRC-related opioid work. The task force's missions include coordinated disruption, investigations, prosecutions, sanctions enforcement, joint operations, raids, tactical actions, referrals, strategies addressing the People's Republic of China, and cooperation with state, territorial, Tribal, and local law enforcement. It creates intelligence coordination, strategic operational planning, general counsel, and congressional coordination offices, but it may not target personal drug use or low-level dealing without significant ties to larger trafficking networks.
Who Benefits and How
Communities harmed by fentanyl trafficking benefit from a federal task force focused on illicit synthetic narcotics networks. Federal prosecutors benefit from coordinated investigative, venue, referral, and tactical support across DOJ, Treasury, DHS, State, Commerce, Defense, and intelligence agencies. State and local law enforcement agencies benefit from memorandums of understanding and coordinated federal operations against larger trafficking networks. Treasury sanctions officers benefit because sanctions enforcement and financial-crime authorities are built into the task force mission. Low-level drug users benefit from the rule of construction excluding personal use and low-level dealing from the task force mandate.
Who Bears the Burden and How
DOJ, DEA, FBI, Treasury, DHS, State, Commerce, Defense, ODNI, and other agencies must assign representatives and share information. The task force Director must prepare 180-day plans, reports, briefings, budget priorities, and operational metrics for Congress. PRC-linked synthetic narcotics traffickers face more coordinated investigations, sanctions, raids, prosecutions, and asset seizures. Federal taxpayers fund a new Executive Schedule level II office and interagency operating structure.
Key Provisions
- Creates the Joint Task Force to Counter Illicit Synthetic Narcotics with a Senate-confirmed Director reporting to the Attorney General.
- Includes DOJ, Treasury, DHS, State, Commerce, Defense, ODNI, and other selected agencies.
- Authorizes investigations, prosecutions, sanctions referrals, intelligence coordination, raids, asset seizures, and strategic planning.
- Requires 180-day congressional reports and briefings on plans, budgets, operations, and PRC-related efforts.
- Limits the task force so it cannot target personal drug use or low-level dealing lacking significant network connections.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
Establishes a Senate-confirmed Joint Task Force to Counter Illicit Synthetic Narcotics, led under the Attorney General, to coordinate federal investigations, prosecutions, sanctions, intelligence, planning, operations, reporting, and PRC-focused trafficking strategy while excluding personal drug use and low-level dealing from its mandate.
Key Policy Areas
Drug Enforcement, Fentanyl, Interagency Coordination, Foreign Affairs
Primary Purpose
Establishes a Senate-confirmed Joint Task Force to Counter Illicit Synthetic Narcotics, led under the Attorney General, to coordinate federal investigations, prosecutions, sanctions, intelligence, planning, operations, reporting, and PRC-focused trafficking strategy while excluding personal drug use and low-level dealing from its mandate.
Policy Domains
Resolution provisions
Identified Gains
- Communities harmed by fentanyl trafficking
- Federal prosecutors
- State law enforcement agencies
- Treasury sanctions officers
- Low-level drug users
Identified Costs
- Department of Justice
- Task force Director
- PRC-linked synthetic narcotics traffickers
- Federal taxpayers
Sponsors
Legislative Progress
In CommitteeMr. Newhouse (for himself, Mr. Moolenaar, Mr. Krishnamoorthi, Mr. Auchincloss, …
Referred to the Committee on the Judiciary, and in addition …
Introduced in House
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Communities harmed by fentanyl trafficking, Low-level drug users
Federal prosecutors, State law enforcement agencies
PRC-linked synthetic narcotics traffickers
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology